Public health & disease

A modern all-electric kitchen with induction cooktop in a Sydney apartment, for an article about Sydney gas appliance ban

City of Sydney bans gas appliances in all new homes starting 2026

By / / Good News For Humankind

Sydney’s gas appliance ban marks a turning point for urban housing policy in Australia. The City of Sydney council voted unanimously to prohibit gas cooking and heating in all new residential buildings from January 2026, making it the seventh New South Wales council to adopt such a measure. The decision matters because it addresses both climate emissions and indoor air quality, with research showing gas cooking can push nitrogen dioxide levels to five times Australia’s outdoor air quality standard within 30 minutes. Councillors say the switch could save households up to 26 annually, while signalling to developers across Australia’s largest city that electric homes are the future.

A patient breathing into a medical device for an article about pancreatic cancer breath test

U.K. breath test for pancreatic cancer could transform early detection

By / / Good News For Humankind

Pancreatic cancer breath test developed by Imperial College London researchers could transform early detection of one of medicine’s deadliest diseases. Scientists identified specific volatile organic compounds in exhaled breath that signal early-stage pancreatic cancer, validated across more than 700 samples. The NHS has now launched a trial at roughly 40 hospital sites across England, Wales, and Scotland, targeting 6,000 patients, with results reaching doctors within three days. Since over 80% of cases are currently diagnosed after the cancer has spread, this fast, portable, low-cost test could shift outcomes from palliative to curative for thousands of patients annually.

A Maldives island health clinic with a mother and newborn for an article about triple elimination mother-to-child transmission

Maldives becomes first country to achieve triple elimination of mother-to-child disease transmission

By / / Good News For Humankind

The Maldives has become the first country in the world to achieve triple elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B, earning official World Health Organization validation in October 2025. The milestone is remarkable not just for what was accomplished but where — across more than 200 inhabited islands scattered over 35,000 square miles of the Indian Ocean. The Maldives succeeded by integrating screening and treatment into routine prenatal care, reaching over 95% of pregnant women including migrants on remote atolls. The achievement offers a replicable model for small island nations worldwide.

A fast-flowing river in West Africa at sunset, for an article about river blindness elimination in Niger — 13 words ✓

Niger becomes first African country free of river blindness

By / / Good News For Humankind

River blindness elimination in Africa has reached a landmark moment: Niger is the first country on the continent declared free of onchocerciasis, following formal World Health Organization verification that transmission of the parasite has been fully interrupted. The achievement closes a cycle of infection that once forced entire communities to abandon fertile river valley land rather than risk permanent blindness. Built on more than 50 years of mass ivermectin distribution, community health networks, and sustained political commitment, Niger’s success proves that elimination targets for neglected tropical diseases are genuinely achievable. The verified milestone also reopens productive agricultural land and signals a realistic path forward for neighboring countries still working toward the same goal.

A person holding an insulin pen for an article about California low-cost insulin program

California launches its own low-cost insulin program at 1 per pen

By / / Good News For Humankind

California’s low-cost insulin program marks a historic first in American healthcare. Starting January 1, 2026, California will sell state-branded insulin pens for just 1 each through its CalRx program, undercutting pharmaceutical prices that can run four to seven times higher. The state partnered with nonprofit manufacturer Civica Rx to produce the biosimilar medication, bypassing the market forces that have made insulin unaffordable for millions. With over 38 million Americans living with diabetes, this publicly backed manufacturing model could offer a replicable blueprint for addressing runaway prescription drug costs nationwide.

Colorized microscopy image of neurons and plaques for an article about Alzheimer's nanoparticle treatment

A single injection reversed Alzheimer’s symptoms in mice, and researchers say humans could be next

By / / Good News For Humankind

Alzheimer’s nanoparticle treatment developed by scientists in Spain and China reversed disease symptoms in mice with a single injection, according to a study published in Nature Nanotechnology. Rather than targeting amyloid-beta plaques directly, the engineered nanoparticles crossed the damaged blood-brain barrier and restored the brain’s own waste-clearance system. Within one hour, researchers recorded a sharp drop in toxic protein levels, with memory function fully restored and effects lasting the equivalent of decades in human terms. While mouse results don’t guarantee human outcomes, the mechanism targeting barrier function over individual markers may prove more durable than previous approaches.

Health workers preparing oral vaccines in a field setting for an article about cholera vaccination campaign in Darfur

Cholera vaccination campaign reaches 1.86 million people in Darfur amid active conflict

By / / Good News For Humankind

Sudan cholera vaccination campaign: In late September 2025, health workers delivered oral cholera vaccines to more than 1.86 million people across six localities in the Darfur states, navigating active conflict, broken infrastructure, and collapsed supply chains to reach nearly 97% of the targeted population. Coordinated by Sudan’s Ministry of Health with WHO, UNICEF, and global partners, the campaign addressed an outbreak spanning all 18 states, with over 113,000 cases and 3,000 deaths recorded since July 2024. Beyond vaccination, teams trained local health workers and delivered hygiene education, building lasting community capacity.

A neuroscientist reviewing brain scan imagery for an article about Huntington's disease gene therapy

U.K. scientists slow Huntington’s disease progression for the first time

By / / Good News For Humankind

Huntington’s disease gene therapy has achieved what researchers once considered impossible, with a single surgical injection slowing overall disease progression by 75% and functional decline by 60% in a University College London clinical trial. The experimental treatment, AMT-130, permanently reprograms neurons to stop producing the toxic protein responsible for destroying brain cells in this fatal inherited disorder. For the roughly 41,000 Americans living with Huntington’s and 200,000 more at genetic risk, the word “stable” now carries real clinical meaning. Beyond one disease, the gene-silencing techniques validated here are accelerating research into Alzheimer’s, Parkinson’s, and other neurological conditions affecting tens of millions worldwide.

A neuroscientist reviewing brain activity data on a monitor for an article about epilepsy drug RAP-219

New epilepsy drug cuts seizures by nearly 80% in mid-stage trial

By / / Good News For Humankind

Epilepsy drug RAP-219 has shown striking results in a mid-stage clinical trial, reducing seizures by a median of 77.8% in adults whose epilepsy had not responded to existing medications. Developed by Rapport Therapeutics, the drug works by precisely targeting overactive brain regions rather than broadly suppressing electrical activity across the whole brain. Nearly one in four participants became completely seizure-free during the eight-week study. The trial’s use of implanted neurostimulation devices provided objective, real-time brain data that strengthens confidence in the findings. Phase 3 trials are expected to begin in 2026.

A rural health worker examines a patient in a Kenyan village for an article about Kenya sleeping sickness elimination

Kenya becomes the 10th African nation to eliminate sleeping sickness

By / / Good News For Humankind

Sleeping sickness elimination in Kenya has earned official World Health Organization validation, making Kenya the 10th African country to reach this public health threshold. The WHO granted formal recognition in June 2025, following Kenya’s last locally transmitted case in 2009 and zero cases since. The achievement required decades of coordinated surveillance, government commitment, and community-level action across six historically affected counties. It also marks Kenya’s second neglected tropical disease elimination win, following Guinea worm disease in 2018 — a record few low- and middle-income countries can match.